NANETS Clinical Investigator Scholarship (NCIS)

Purpose

The NANETS Clinical Investigator Scholarship encourages clinicians at the end of their fellowship or beginning of their faculty appointment to pursue a clinical career focused on neuroendocrine tumors. The NCIS emphasizes both the professional development of the scientific clinician (whose time is primarily dedicated to patient care) and the potential of the project to directly impact NET patients.

Award Sponsor

Ipsen Biopharmaceuticals has supported this grant since 2010. Ipsen offers this award in honor of Edda Gomez-Panzani, MD for her dedication and work on behalf of patients living with neuroendocrine tumors.

Eligibility

The NANETS Clinical Investigator Scholarship encourages clinicians at the end of their fellowship or beginning of their faculty appointment to pursue a clinical career focused on neuroendocrine tumors. The NCIS emphasizes both the professional development of the scientific clinician (whose time is primarily dedicated to patient care) and the potential of the project to directly impact NET patients.

NANETS welcomes applications from candidates who meet the following criteria:

  • Candidates must have a MD, PhD, MD/PhD, DO degree or equivalent.
  • At the time of funding, candidates must be:
    • Within 6 years of starting their first faculty position and currently have an academic appointment at an accredited medical school or other institution in North America,
    • OR hold a postdoctoral fellowship appointment at an accredited medical school or other institution in North America.
  • Candidates must be a NANETS member in good standing.
  • Previous recipients of NBTSI, NCIS or NTIG awards are not eligible to apply.

Selection Criteria

Criteria for selection will include both the clinical project itself and the potential of the individual to make future clinical contributions to the neuroendocrine tumor field. Strong emphasis will be placed on the career development plan and the applicant’s personal statements and the mentor’s development plan. The clinical proposal section should focus on a project with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors. Appropriate projects would include (but are not limited to) correlative studies involving existing clinical trials, retrospective studies, a NET database, risk factors and/or any project with a clear clinical significance.

Award Term

The NANETS Clinical Investigator Scholarship Award is a two-year $100,000 grant, awarding $50,000 in funding each year. The award period begins January 1.

Reporting Requirements

The recipient must provide NANETS with a written progress report of the project and a budget reconciliation annually. 

Application Review and Notification Process

Applications are reviewed and scored by the NANETS’ Scientific Review & Research Committee comprised of NET medical research experts. Criteria for selection will include both the research proposal itself and the potential of the individual to make future scientific and/or clinical contributions to the neuroendocrine tumor field. Strong emphasis will be placed on the career development plan and the applicant’s personal statements, as well as the research proposal. The research proposals section should focus on research projects with the potential to directly impact and improve the treatment of patients with neuroendocrine tumors. Appropriate projects would include (but are not limited to) studies of neuroendocrine tumor biology, epidemiology, risk factors, clinical outcomes, novel treatment strategies, and translational research projects with clear clinical significance.  

Disclaimer
Funding is subject to the approval and availability of grant funds appropriated to NANETS. Therefore, NANETS reserves the right to alter the number of investigator awards, terms and allowances.